asa guidelines for glp-1 agonists Glucagon-Like Peptide-1 Receptor in Perioperative Care ASA Advises No Longer Holding
Description
Hussain A, Ashique S, Afzal O, et al
As the World Health Organization recently issued guidance supporting the use of GLP-1 medications in obesity care, these drugs reached a new milestone
Semaglutide and tirzepatide achieve approximately 15-20% body weight reduction in clinical trials
Nov 1 2023;12(11)doi:10.1530/ec-23-0257 Wilding JPH, Batterham RL, Davies M, et al
[Google Scholar] 38.Martin MA, Molina JA, Jimenez-Jimenez FJ, Benito-Leon J, Orti-Pareja M, Campos Y, et al
To maintain accuracy in your care, we require a mandatory initial assessment before your physical and consultation
